$HSTC
HST Global Inc

2019 Q3 Form 10-Q Financial Statement

#000167479619000084 Filed on August 20, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $55.01K $34.76K $34.62K
YoY Change 58.8% -13.1% 15.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $55.01K $34.76K $34.62K
YoY Change 58.8% -13.1% 15.4%
Operating Profit -$55.01K -$34.76K
YoY Change 58.81% -1.97%
Interest Expense $0.00 -$8.940K -$8.940K
YoY Change -100.0% -10.6% -10.6%
% of Operating Profit
Other Income/Expense, Net $596.0K -$8.937K $0.00
YoY Change 0.0%
Pretax Income $541.0K -$43.70K -$43.55K
YoY Change -1341.37% 9.25% 8.88%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $541.0K -$43.70K -$43.55K
YoY Change -1341.37% 9.25% 8.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $156.5K -$17.69K -$17.79K
COMMON SHARES
Basic Shares Outstanding 51.72M shares 36.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.95K $0.00 $0.00
YoY Change
Cash & Equivalents $16.95K $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $5.100K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $22.05K $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $22.05K $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $22.05K $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $96.73K $509.2K
YoY Change -100.0% -81.03% -0.16%
Accrued Expenses $0.00 $193.2K $1.487M
YoY Change -100.0% -86.3% 11.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $675.0K $1.375M
YoY Change -100.0% -50.73% 1.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $0.00 $964.9K $3.371M
YoY Change -100.0% -70.58% 5.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $0.00 $964.9K $3.371M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $964.9K $3.371M
YoY Change -100.0% -70.58% 5.67%
SHAREHOLDERS EQUITY
Retained Earnings -$5.340M -$5.881M -$5.792M
YoY Change -7.11% 3.09% 3.18%
Common Stock $63.72K $51.72K $2.448K
YoY Change 73.53% 40.85% -93.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.05K -$964.9K -$3.371M
YoY Change
Total Liabilities & Shareholders Equity $22.05K $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q4
OPERATING ACTIVITIES
Net Income $541.0K -$43.70K -$43.55K
YoY Change -1341.37% 9.25% 8.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$63.81K -$13.10K -$4.500K
YoY Change 868.29% 31.0% -55.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.76K 13.10K 4.500K
YoY Change 1181.9% 31.0% -55.0%
NET CHANGE
Cash From Operating Activities -63.81K -13.10K -4.500K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 80.76K 13.10K 4.500K
Net Change In Cash 16.95K 0.000 0.000
YoY Change -5944.83%
FREE CASH FLOW
Cash From Operating Activities -$63.81K -$13.10K -$4.500K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Entity File Number
EntityFileNumber
000-15303
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Entity Registrant Name
EntityRegistrantName
HST Global, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1215433
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Research Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Hampton
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23666
dei City Area Code
CityAreaCode
757
dei Local Phone Number
LocalPhoneNumber
766-6100
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51719854 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2019Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2018Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2019Q2 us-gaap Assets
Assets
0 usd
CY2018Q4 us-gaap Assets
Assets
0 usd
CY2019Q2 us-gaap Bank Overdrafts
BankOverdrafts
3702 usd
CY2018Q4 us-gaap Bank Overdrafts
BankOverdrafts
2957 usd
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0 usd
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3.228 usd
CY2019Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
96728 usd
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
505959 usd
CY2019Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
70000 usd
CY2018Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1110000 usd
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
123176 usd
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
376629 usd
CY2019Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
671300 usd
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1372169 usd
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
964906 usd
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3370942 usd
CY2019Q2 us-gaap Liabilities
Liabilities
964906 usd
CY2018Q4 us-gaap Liabilities
Liabilities
3370942 usd
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51719854 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51719854 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36719854 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36719854 shares
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
51720 usd
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
36720 usd
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4864800 usd
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2384824 usd
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5881426 usd
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5792486 usd
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-964906 usd
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-3370942 usd
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2018Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2018Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
60000 usd
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5456 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11066 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13332 usd
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
35456 usd
us-gaap Operating Expenses
OperatingExpenses
71066 usd
us-gaap Operating Expenses
OperatingExpenses
73332 usd
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-35456 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-71066 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-73332 usd
CY2018Q2 us-gaap Interest Expense
InterestExpense
-8937 usd
us-gaap Interest Expense
InterestExpense
-17874 usd
us-gaap Interest Expense
InterestExpense
-17874 usd
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8937 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17874 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17874 usd
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44393 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88940 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-91206 usd
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-44393 usd
us-gaap Net Income Loss
NetIncomeLoss
-88940 usd
us-gaap Net Income Loss
NetIncomeLoss
-91206 usd
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36885600 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
us-gaap Profit Loss
ProfitLoss
-91206 usd
us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
2342 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1101 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
60000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17874 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12091 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
11800 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11800 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-291 usd
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="font-size:10pt"><b>NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES </b></span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-size:10pt">HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations.  Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.</span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-size:10pt">HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases.  In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.</span></p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="font-size:10pt;border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-size:10pt">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.  </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="font-size:10pt;border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font-size:10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>

Files In Submission

Name View Source Status
0001674796-19-000084-index-headers.html Edgar Link pending
0001674796-19-000084-index.html Edgar Link pending
0001674796-19-000084.txt Edgar Link pending
0001674796-19-000084-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstc-20190630.htm Edgar Link pending
hstc-20190630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
hstc-20190630_def.xml Edgar Link unprocessable
hstc-20190630_lab.xml Edgar Link unprocessable
hstc-20190630_cal.xml Edgar Link unprocessable
hstc-20190630_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hstc-20190630_pre.xml Edgar Link unprocessable